SLC5A2 and cardiac hypertrophy: Compared with SGLT2 inhibitor's beneficial effects, the Na/K-ATPase and its signaling function exert some similar effects mainly through the kidney, such as natriuresis, blood pressure-lowering, and through the heart, such as reduction of cardiac hypertrophy and fibrosis.